Compare Nuwellis Inc (NUWE) vs Payoneer Global Inc (PAYO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Payoneer Global Inc — how do they compare? Nuwellis Inc trades at $0.68 (market cap $2.20M), while Payoneer Global Inc trades at $7.19 (market cap $2.43B). The key difference: Payoneer Global Inc is far larger — about 1104.5× Nuwellis Inc's market cap, and Payoneer Global Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 26 Days and Payoneer Global Inc for 61 Days on average.
| NUWE | PAYO | |
|---|---|---|
Market Cap | $2.20M | $2.43B |
Volume | 121,544 | 1,601,413 |
Sector | Health | Technology |
52-Week High | $146.65 | $7.18 |
52-Week Low | $0.68 | $4.27 |
Typical Hold Time | 26 Days | 61 Days |
Enterprise Value | -$1.52M | $2.17B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Payoneer Global (PAYO) trades at $7.16, up 0.14% with a bullish technical signal from moving averages. The company reported mixed quarterly earnings, beating Q1 2026 estimates but missing Q2 2026. Revenue grew to $821M in 2025, though net income margin compressed to 5.83%. Recent news highlights Payoneer's renewed partnership with Etsy through 2029 and a pending acquisition by Nuvei announced in June 2026.
The outlook is clouded by earnings volatility and acquisition uncertainty, but analyst sentiment remains positive with 60% buy ratings. Key risks include integration challenges post-acquisition and competitive pressures in fintech. The stock's elevated P/E of 51.14 suggests growth expectations must materialize to justify valuation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Payoneer Global Inc
Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →
